An Observational Study of Dose Dense Chemotherapy With Lipegfilgrastim Support

Trial Profile

An Observational Study of Dose Dense Chemotherapy With Lipegfilgrastim Support

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Aug 2017

At a glance

  • Drugs Lipegfilgrastim (Primary)
  • Indications Breast cancer; Male breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Jul 2016 Status changed from recruiting to active, no longer recruiting.
    • 12 Dec 2015 Trial design presented at the 38th Annual San Antonio Breast Cancer Symposium.
    • 21 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top